BioSpace News Archive

Pictured: Pills spilling out of bottle/artisteer/i

Drug Development

Treatment Approach to Depression Sees Paradigm Shift

New therapeutics for Major Depressive Disorder could change the treatment landscape and give patients more options.

April 13, 2023

·

6 min read

·

Lisa Munger

Drug Development

Merck’s BTK Inhibitor Evobrutinib Slapped with Partial Clinical Hold

Liver toxicities triggered a partial clinical hold on Merck KGaA’s trial studying its BTK inhibitor candidate for multiple sclerosis.

April 13, 2023

·

3 min read

·

Tristan Manalac

Pictured: The Statue of Justice/courtesy of iStock

Policy

Pfizer and BioNTech Sued for Patent Infringement Over mRNA Vaccine

The lawsuit, brought by Arbutus Biopharma, marks the latest legal action in an ongoing battle for intellectual property underlying mRNA vaccines for COVID-19.

April 13, 2023

·

5 min read

·

Catherine Offord

Pictured: Stack of $100 bills / iStock, Nattakorn

Drug Development

Alentis Wins $105M in Series C to Advance Claudin-1-Based Therapies

The company has several targeted therapeutics in early-stage trials and preclinical development for cancer types with high expression levels of the protein.

April 13, 2023

·

2 min read

·

Tristan Manalac

micrograph of pancreas tissue, typical pancreatic tissue in the jejunum tissue

Aspect Biosystems and Novo Nordisk to Tackle Type 1 Diabetes and Obesity

The new partnership involves an initial payout of $75 million and the potential for up to $2.6 billion in milestone funding.

April 13, 2023

·

4 min read

·

Amanda Heidt

Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1

Alentis Therapeutics, the Claudin-1 company, is a clinical-stage biotech developing breakthrough treatments for organ fibrosis and CLDN1 positive tumors.

April 13, 2023

·

6 min read

Biotech Bay

Genentech Data Highlights Strength of Ophthalmology Portfolio and Commitment to Advancing Eye Care at ARVO 2023

Genentech, a member of the Roche Group, announced that new data for its approved and investigational medicines will be highlighted in 30 abstracts at the 2023 Association for Research in Vision and Ophthalmology Annual Meeting, which will be held from April 23-27 in New Orleans, LA.

April 13, 2023

·

12 min read

Angle PLC Announces Pharma Services Contract with Crescendo Biologics

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited.

April 13, 2023

·

8 min read

Genetown

BioVentrix® Closes $48.5 Million Series A Financing

BioVentrix, Inc., a privately held medical device company developing minimally invasive therapies to directly treat the dilated left ventricle and reverse the left ventricular remodeling process in patients with congestive heart failure, announced the completion of $48.5 million Series A round financing.

April 13, 2023

·

2 min read

FDA

Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

Candesant Biomedical today announced the U.S. Food and Drug Administration (FDA) granted a de novo request for Brella™, the first and only 3-Minute SweatControl Patch™ for the reduction of excessive underarm sweating in adults with primary axillary hyperhidrosis.

April 13, 2023

·

7 min read